KMID : 0857220060100020162
|
|
Journal of the Korean Pediatric Cardiology Society 2006 Volume.10 No. 2 p.162 ~ p.170
|
|
The Usefulness of N-terminal Pro-Brain Natriuretic Peptide in the Diagnosis of the Kawasaki Disease
|
|
Hong Jeong-Mi
Moon Yoon-Hee Yoon Kyung-Lim Cha Sung-Ho Yoo Kyung-Hee Han Mi-Young
|
|
Abstract
|
|
|
Purpose: Kawasaki disease (KD) is a well-known generalized vasculitis involving cardiovascular system and there is no specific biochemical marker for detecting this disease. We performed a study to investigate the usefulness of plasma NT-proBNP as a biochemical marker for the diagnosis of KD.
Methods: We measured the plasma NT-proBNP concentrations in acute (complete KD, n=48; incomplete KD, n=10) and convalescent (n=31) phases of KD, and in patients with other acute febrile diseases (n=24) associated with rash or cervical lymphadenitis.
Results: The plasma NT-proBNP concentrations in patients with both complete and incomplete KD in the acute phase were significantly higher than in those with febrile illness (complete KD, 1211.9¡¾1653.7 pg/mL; incomplete KD, 2245.9¡¾2720.7 pg/mL versus febrile illness, 138.8¡¾104.9 pg/mL; P£¼0.001). Also, the level of plasma NT-proBNP decreased significantly in the convalescent phase compared with level of NT-proBNP in acute phase (n=31, acute phase, 1390.2¡¾1891.8 pg/ml; convalescent phase, 88.3¡¾125.3 pg/mL; P£¼0.001). There were no significant correlations between the plasma concentrations of NT-proBNP and the clinical, laboratory and echocardiographic findings of acute phase of KD. The best cut-off level of NT-proBNP for the differential diagnosis of KD with other febrile disease was determined to be 287.0 pg/mL (sensitivity 0.862, specificity 0.917).
Conclusion: We suggest that the measurement of plasma NT-proBNP level may be helpful for the definite diagnosis of KD, especially incomplete KD. Further studies are needed to investigate the usefulness of the NT-proBNP as a predictive marker for cardiovascular complications.
|
|
KEYWORD
|
|
N-terminal pro-brain natriuretic peptide, Kawasaki disease
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|